Cargando…

Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review

Visceral leishmaniasis is one of the deadliest parasitic diseases in the world and affects both humans and dogs. The host immune response to Leishmania infection plays a critical role in the evolution of canine visceral leishmaniasis (CVL) and consequently in the manifestation of clinical signs. The...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Castro, Ana, Egui, Adriana, Thomas, María Carmen, López, Manuel Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229064/
https://www.ncbi.nlm.nih.gov/pubmed/35746555
http://dx.doi.org/10.3390/vaccines10060947
_version_ 1784734643722911744
author García-Castro, Ana
Egui, Adriana
Thomas, María Carmen
López, Manuel Carlos
author_facet García-Castro, Ana
Egui, Adriana
Thomas, María Carmen
López, Manuel Carlos
author_sort García-Castro, Ana
collection PubMed
description Visceral leishmaniasis is one of the deadliest parasitic diseases in the world and affects both humans and dogs. The host immune response to Leishmania infection plays a critical role in the evolution of canine visceral leishmaniasis (CVL) and consequently in the manifestation of clinical signs. The asymptomatic form of the disease is a major concern in the diagnosis of CVL and in the transmission control of Leishmania infection. Asymptomatic dogs are found in large proportions in endemic areas and are an unquantifiable source of infection. The present review analyzes the possible relationship between the activation of the antigen-specific immune response of the host and resistance or susceptibility to CVL. The review focuses on works that address the characterization of the humoral and cellular immune response profile, at both the functional and phenotypic levels, in infected dogs. Most studies relate the absence of clinical symptomatology to an increased proliferative response and a Th1 cytokine profile. Despite the numerous findings pointing to a differential immune response in asymptomatic dogs, the contradictory results reported in this review highlight the importance of establishing a precise clinical classification of the disease, performing more longitudinal studies, and including a higher number of animals in trials.
format Online
Article
Text
id pubmed-9229064
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92290642022-06-25 Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review García-Castro, Ana Egui, Adriana Thomas, María Carmen López, Manuel Carlos Vaccines (Basel) Review Visceral leishmaniasis is one of the deadliest parasitic diseases in the world and affects both humans and dogs. The host immune response to Leishmania infection plays a critical role in the evolution of canine visceral leishmaniasis (CVL) and consequently in the manifestation of clinical signs. The asymptomatic form of the disease is a major concern in the diagnosis of CVL and in the transmission control of Leishmania infection. Asymptomatic dogs are found in large proportions in endemic areas and are an unquantifiable source of infection. The present review analyzes the possible relationship between the activation of the antigen-specific immune response of the host and resistance or susceptibility to CVL. The review focuses on works that address the characterization of the humoral and cellular immune response profile, at both the functional and phenotypic levels, in infected dogs. Most studies relate the absence of clinical symptomatology to an increased proliferative response and a Th1 cytokine profile. Despite the numerous findings pointing to a differential immune response in asymptomatic dogs, the contradictory results reported in this review highlight the importance of establishing a precise clinical classification of the disease, performing more longitudinal studies, and including a higher number of animals in trials. MDPI 2022-06-14 /pmc/articles/PMC9229064/ /pubmed/35746555 http://dx.doi.org/10.3390/vaccines10060947 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
García-Castro, Ana
Egui, Adriana
Thomas, María Carmen
López, Manuel Carlos
Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review
title Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review
title_full Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review
title_fullStr Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review
title_full_unstemmed Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review
title_short Humoral and Cellular Immune Response in Asymptomatic Dogs with Visceral Leishmaniasis: A Review
title_sort humoral and cellular immune response in asymptomatic dogs with visceral leishmaniasis: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229064/
https://www.ncbi.nlm.nih.gov/pubmed/35746555
http://dx.doi.org/10.3390/vaccines10060947
work_keys_str_mv AT garciacastroana humoralandcellularimmuneresponseinasymptomaticdogswithvisceralleishmaniasisareview
AT eguiadriana humoralandcellularimmuneresponseinasymptomaticdogswithvisceralleishmaniasisareview
AT thomasmariacarmen humoralandcellularimmuneresponseinasymptomaticdogswithvisceralleishmaniasisareview
AT lopezmanuelcarlos humoralandcellularimmuneresponseinasymptomaticdogswithvisceralleishmaniasisareview